Targeting mitochondrial apoptosis during EBV infection would have the advantage of potentially inhibiting both TGF-β and BCR-induced death, whereas FAS-induced apoptosis (which is independent of the BCL-2 family and mitochondria) would need to be targeted selectively. The gene discussed is TGFB1; the disease is Epstein-Barr virus infection.